Fresenius Medical Care consensus shapes Thursday view, shares tracked against 200-day line
25.06.2026 - 20:28:07 | ad-hoc-news.de
By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-25, 20:27.
Fresenius Medical Care (DE0005785802) starts Thursday trading on Xetra with a broadly constructive analyst stance, while the stock trades around its 200-day moving average according to recent chart data. Consensus data compiled by MarketScreener show a mix of Buy and Hold views from major brokers. MarketScreener consensus overview for Fresenius Medical Care
What analysts are signaling now
Across the analyst community, large houses such as Deutsche Bank, UBS and JPMorgan have recently reiterated broadly neutral to positive views on Fresenius Medical Care, with several 12-month price targets pointing to moderate upside versus recent Xetra levels. Finanzen.net analyst summary for Fresenius Medical Care
According to aggregated estimates for the current fiscal year, analysts expect Fresenius Medical Care to deliver mid-single-digit revenue growth and further margin recovery after restructuring measures in its North American dialysis operations. Reuters analysis page on Fresenius Medical Care
Thursday focus on technical levels
On Thursday, investors are watching how Fresenius Medical Care shares behave relative to the 200-day line, a key long-term technical level often used by institutional investors for trend assessment; recent data show the indicator not far from the current Xetra price region. TradingView chart for Fresenius Medical Care on Xetra
With the broader STOXX Europe 600 Health Care index trading near recent highs, valuations across dialysis peers such as DaVita and other renal-care providers are also under scrutiny, as relative performance versus sector benchmarks shapes positioning decisions. Fresenius Medical Care investor presentation and reports
All news and analysis on the Fresenius Medical Care shares
More headlines, data and background on Fresenius Medical Care, including previous earnings, guidance comments and market reactions.
The product behind the stock
Fresenius Medical Care generates most of its revenue from dialysis services and related products, including hemodialysis machines such as the 5008 CorDiax and a broad portfolio of dialyzers and disposables used in chronic kidney failure treatment worldwide.
Where the stock trades today
Fresenius Medical Care shares most recently traded on Xetra around their 200-day moving average, with the latest available quote and market capitalization data published on Deutsche Boerse and other price platforms as of the last completed trading session.
Fresenius Medical Care at a glance
- Company: Fresenius Medical Care AG & Co. KGaA
- ISIN: DE0005785802
- WKN: 578580
- Ticker: FME
- Trading venue: Xetra
- Price (as of 2026-06-25, 18:00): 00.00 EUR
- Market cap: 00.00 EUR (as of 2026-06-25)
- Sector / industry: Health Care - Renal Care & Dialysis Services
- Index membership: DAX
- Next earnings date: not officially scheduled
This article was produced with AI assistance and editorially reviewed. Price and company figures without guarantee; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Stock-market transactions carry risks up to and including total loss.
